Price T Rowe Associates Inc Cor Medix Inc. Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Cor Medix Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 14,635 shares of CRMD stock, worth $60,296. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,635
Previous 12,073
21.22%
Holding current value
$60,296
Previous $46,000
36.96%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CRMD
# of Institutions
95Shares Held
17.1MCall Options Held
92.9KPut Options Held
293K-
Black Rock Inc. New York, NY3.49MShares$14.4 Million0.0% of portfolio
-
Nomura Holdings Inc Tokyo, M02.95MShares$12.2 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.93MShares$12.1 Million0.0% of portfolio
-
Paul Singer Elliott Investment Management L.P. | West Palm Beach, Fl1.55MShares$6.39 Million0.04% of portfolio
-
Geode Capital Management, LLC Boston, MA1.18MShares$4.87 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $170M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...